Detalhe da pesquisa
1.
A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data.
Genome Res
; 34(1): 94-105, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195207
2.
Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions.
Blood
; 141(23): 2797-2812, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947811
3.
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common ß-chain cytokine receptor endocytosis.
Blood
; 139(5): 761-778, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780648
4.
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Blood
; 139(8): 1208-1221, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482403
5.
Comparison of colorimetric, fluorometric, and liquid chromatography-mass spectrometry assays for acetyl-coenzyme A.
Anal Biochem
; 685: 115405, 2024 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016493
6.
Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.
Proc Natl Acad Sci U S A
; 118(51)2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916286
7.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Blood
; 138(21): 2042-2050, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407543
8.
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
Haematologica
; 108(6): 1567-1578, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727397
9.
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia.
Curr Treat Options Oncol
; 24(8): 1036-1051, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300657
10.
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
N Engl J Med
; 381(24): 2315-2326, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826340
11.
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia.
Am J Hematol
; 97(11): 1419-1426, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054756
12.
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference.
J Allergy Clin Immunol
; 147(6): 2043-2052, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745886
13.
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.
Blood
; 134(26): 2388-2398, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697804
14.
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.
Blood
; 134(11): 867-879, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31366621
15.
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.
Acta Haematol
; 144(4): 458-464, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412552
16.
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
N Engl J Med
; 376(10): 917-927, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273028
17.
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
Blood
; 132(4): 393-404, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567798
18.
Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature.
Haematologica
; 105(12): 2795-2804, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256378
19.
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(10): 1385-1415, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022644
20.
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(9): 1248-1269, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886902